Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 4.79% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Driving Catalysts
Lancaster Colony recently hiked its quarterly dividend by 5.56% to 38 cents from 36 cents. Apart from the regular cash dividend, the company will also pay a special cash dividend of $5.00 per share to shareholders on December 28, 2012.
On October 25, the company reported solid fiscal first-quarter earnings per share of 98 cents, up 25.6% year over year and 4.3% above the Zacks Consensus Estimate. Net sales jumped 6.0% year over year to $291 million. Segment-wise, Specialty Foods net sales nudged up 5%, driven by increases in both retail and foodservice sales, while Glassware and Candles sales increased 12% on volume growth.
Rising Earnings Estimate Revisions
The Zacks Consensus Estimate for fiscal 2013 rose 2.0% to $4.04 per share in the last 30 days, based on upward revisions from 2 of 3 estimates. This outlook implies year-over-year growth of 15.2%.
For fiscal 2014, the Zacks Consensus Estimate is up 4.3% to $4.35 per share, suggesting year-over-year growth of 7.6%.
Reasonable Valuation
Though the stock of Lancaster Colony is not cheap by most valuation metrics, it looks reasonable on a P/E basis. The stock currently trades at a forward P/E of 18.13x, a slight discount to the peer group average of 18.39x. The stock also looks attractive given a trailing 12-month ROE of 18.1%, which is higher than the peer group average of 9.2%.
Chart Shows Promise
Over the past six months, the stock has gained approximately 14.4%, compared with the S&P 500s return of 7.1%. It has also been consistently trading above its 200-day moving average since May 25, 2012. Volume is fairly strong, averaging roughly 153K daily.
Founded in 1961, Lancaster Colony Corporation is headquartered in Columbus, Ohio and manufactures and markets consumer products, primarily specialty foods in the United States. The company operates in two segments Specialty Foods and Glassware and Candles. With a market capitalization of $2 billion, Lancaster primarily competes with General Mills, Inc. (GIS) and Mondelez International, Inc. (MDLZ).
Want More of Our Best Recommendations?
Zacks' Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Then each week he hand-selects the most compelling trades and serves them up to you in a new program called Zacks Confidential.
Learn More>>
Read the full reports :
Snapshot Report on LANC